Overview of included patients according to aaIPI and first-line therapy
| Number of patients . | R-ACVBP (n = 455) . | R-CHOP (n = 1304) . | R-CHOEP (n = 444) . |
|---|---|---|---|
| aaIPI of 0 without bulk (n = 652) | |||
| LNH03-1B | 76 | ||
| FLYER | — | 399 | |
| MInT | — | 58 | 55 |
| UNFOLDER | — | 64 | — |
| aaIPI of 1 (n = 924) | |||
| LNH03-2B | 134 | 134 | — |
| MInT | — | 105 | 85 |
| UNFOLDER | — | 466 | — |
| aaIPI of 2-3 (n = 627) | |||
| LNH03-3B | 164 | — | — |
| LNH07-3B∗ | 81 | 78 | |
| MegaCHOEP phase 2 | — | — | 47 |
| MegaCHOEP phase 3 | — | — | 189 |
| DENSE-R-MegaCHOEP | — | — | 68 |
| Number of patients . | R-ACVBP (n = 455) . | R-CHOP (n = 1304) . | R-CHOEP (n = 444) . |
|---|---|---|---|
| aaIPI of 0 without bulk (n = 652) | |||
| LNH03-1B | 76 | ||
| FLYER | — | 399 | |
| MInT | — | 58 | 55 |
| UNFOLDER | — | 64 | — |
| aaIPI of 1 (n = 924) | |||
| LNH03-2B | 134 | 134 | — |
| MInT | — | 105 | 85 |
| UNFOLDER | — | 466 | — |
| aaIPI of 2-3 (n = 627) | |||
| LNH03-3B | 164 | — | — |
| LNH07-3B∗ | 81 | 78 | |
| MegaCHOEP phase 2 | — | — | 47 |
| MegaCHOEP phase 3 | — | — | 189 |
| DENSE-R-MegaCHOEP | — | — | 68 |
PET-guided trial.